Skip to main content
. 2026 May 7;11(5):aakag044. doi: 10.1093/esj/aakag044

Figure 16.

Pooled results show a reduction in SAP incidence compared with no statins, with risk of bias ranging from some concerns to low across studies.

Forest plot and risk-of-bias assessment of statins for SAP incidence. aConfidence interval (CI) calculated with Wald-type method. bTau2 calculated with DerSimonian and Laird method. Risk of bias legend: (A) bias arising from the randomization process, (B) bias due to deviations from intended interventions, (C) bias due to missing outcome data, (D) bias in measurement of the outcome, (E) bias in selection of the reported result, (F) overall bias. Inline graphic High, Inline graphic some concerns, Inline graphic low, Inline graphic No information.